metformin has been researched along with pentylenetetrazole in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Liu, LM; Wang, WP; Xu, F; Xu, XC; Zhang, WL; Zhao, RR | 1 |
| Hu, Y; Li, Y; Wang, X; Yang, Y; Zhang, Y; Zheng, F; Zhu, B | 1 |
| Sánchez, MP; Sánchez-Elexpuru, G; Sanz, P; Serratosa, JM | 1 |
| Chen, J; Guo, H; Jiang, J; Liu, XY; Shi, ZN; Wang, XY; Yang, X; Zheng, G | 1 |
| Abbas, KM; Abulseoud, OA; Ali, AN; El-Mesery, M; El-Shafey, M; Eldosoky, M; Hussein, AM | 1 |
| Arcidiacono, B; Brunetti, A; Citraro, R; Constanti, A; De Sarro, G; Leo, A; Nesci, V; Russo, E; Tallarico, M | 1 |
| Nieoczym, D; Pieróg, M; Samorek-Pieróg, M; Socała, K; Wlaź, P; Wyska, E | 1 |
8 other study(ies) available for metformin and pentylenetetrazole
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice.
Topics: Animals; Antioxidants; Brain; Convulsants; Glutathione; Kindling, Neurologic; Learning Disabilities; Male; Malondialdehyde; Maze Learning; Memory Disorders; Metformin; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Pentylenetetrazole; Seizures | 2014 |
Chronic metformin treatment facilitates seizure termination.
Topics: AMP-Activated Protein Kinases; Animals; Male; Metformin; Mice; Mice, Inbred BALB C; Pentylenetetrazole; Seizures | 2017 |
4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease.
Topics: Animals; Anticonvulsants; Brain; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Lafora Disease; Metformin; Mice; Mice, Inbred C57BL; Mice, Knockout; Pentylenetetrazole; Phenylbutyrates; Ubiquitin-Protein Ligases | 2017 |
The effect of metformin treatment on endoplasmic reticulum (ER) stress induced by status epilepticus (SE) via the PERK-eIF2α-CHOP pathway.
Topics: Animals; Apoptosis; Convulsants; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Hypoglycemic Agents; Metformin; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Signal Transduction; Status Epilepticus; Transcription Factor CHOP | 2018 |
Effects of metformin on apoptosis and α-synuclein in a rat model of pentylenetetrazole-induced epilepsy.
Topics: alpha-Synuclein; Animals; Apoptosis; Convulsants; Epilepsy; Male; Metformin; Pentylenetetrazole; Rats; Rats, Sprague-Dawley | 2019 |
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Blood Glucose; Body Composition; Depression; Diet, High-Fat; Disease Susceptibility; Glucose Transporter Type 1; Glucose Transporter Type 3; Kindling, Neurologic; Male; Memory; Metformin; Mice; Open Field Test; Pentylenetetrazole; Seizures; Swimming | 2020 |
Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment.
Topics: AMP-Activated Protein Kinases; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Epilepsy; Metformin; Mice; Pentylenetetrazole; Seizures | 2023 |